Find out how to access preview-only content
Lipopeptides as anti-infectives: a practical perspective
- Giovanna Pirri,
- Andrea Giuliani,
- Silvia Fabiole Nicoletto,
- Lorena Pizzuto,
- Andrea C. Rinaldi
- … show all 5 hide
Purchase on Springer.com
$39.95 / €34.95 / £29.95 *
* Final gross prices may vary according to local VAT.
Abstract
Lipopeptide antibiotics represent an old class of antibiotics that were discovered over 50 years ago, which includes the old polymyxins but also new entries, such as the recently approved daptomycin. They generally consist of a hydrophilic cyclic peptide portion attached to a fatty acid chain which facilitates insertion into the lipid bilayer of bacterial membranes. This review presents an overview of this class of antibiotics, focusing on their therapeutic applications and putting particular emphasis on chemical modifications introduced to improve their activity.
Related Content
Supplementary Material (0)
References (106)
- Nathan C., Goldberg F.M., The profit problem in antibiotic R&D, Nat. Rev. Drug Discov., 2005, 4, 887–891 CrossRef
- Payne D.J., Gwynn M.N., Holmes D.J., Pompliano D.L., Drugs for bad bugs: confronting the challenges of antibacterial discovery, Nat. Rev. Drug Discov., 2007, 6, 29–40 CrossRef
- Jerala R., Synthetic lipopeptides: a novel class of anti-infectives, Expert Opin. Investig. Drugs, 2007, 16, 1159–1169 CrossRef
- Strieker M., Marahiel M.A., The structural diversity of acidic lipopeptide antibiotics, ChemBioChem, 2009, 10, 607–616 CrossRef
- Martin N.I., Hu H., Moake M.M., Churey J.J., Whittal R., Worobo R.W., et al., Isolation, structural characterization, and properties of Mattacin (polymyxin M), a cyclic peptide antibiotic produced by Paenibacillus kobensis M, J. Biol. Chem., 2003, 278, 13124–13132 CrossRef
- Arnold T.M., Forrest G.N., Messmer K.J., Polymyxin antibiotics for gram-negative infections, Am. J. Health Syst. Pharm., 2007, 64, 819–826 CrossRef
- Zavascki A.P., Goldani L.Z., Li J., Nation R.L., Polymyxin B for the treatment of multidrugresistant pathogens: a critical review, J. Antimicrob. Chemother., 2007, 60, 1206–1215 CrossRef
- Denning D.W., Echinocandin antifungal drugs, Lancet, 2003, 362, 1142–1151 CrossRef
- Tossi A., Host defense peptides: roles and applications, Curr. Prot. Pept. Sci., 2005, 6, 1–3 CrossRef
- Giuliani A., Pirri G., Fabiole Nicoletto S., Antimicrobial peptides: an overview of a promising class of therapeutics, Cent. Eur. J. Biol., 2007, 2, 1–33 CrossRef
- Hancock R.E.W., Sahl H.-G., Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies, Nat. Biotechnol., 2006, 24, 1551–1557 CrossRef
- Radek K., Gallo G., Antimicrobial peptides: natural effectors of the innate immune system, Semin. Immunopathol., 2007, 29, 27–43 CrossRef
- Giuliani A., Pirri G., Bozzi A., Di Giulio A., Aschi M., Rinaldi A.C., Antimicrobial peptides: natural templates for synthetic membrane-active compounds, Cell. Mol. Life Sci., 2008, 65, 2450–2460 CrossRef
- Scott R.W., DeGrado W.F., Tew G.N., De novo designed synthetic mimics of antimicrobial peptides, Curr. Opin. Biotechnol., 2008, 19, 620–627 CrossRef
- Moyle P.M., Toth I., Self-adjuvanting lipopeptide vaccines, Curr. Med. Chem., 2008, 15, 505–516 CrossRef
- Ongena M., Jacques P., Bacillus lipopeptides: versatile weapons for plant disease biocontrol, Trends Microbiol., 2007, 16, 115–125 CrossRef
- Debono M., Barnhart M., Carrelll C.B., Hoffmann J.A., Occolowitz J.L., Abbott B.J., et al., A21978C, a complex of new acidic peptide antibiotics: isolation, chemistry, and mass spectral structure elucidation, J. Antibiot. (Tokyo), 1987, 40, 761–777
- Lakey J.H., Lea E.J., Rudd B.A., Wright H.M., Hopwood D.A., A new channel-forming antibiotic from Streptomyces coelicolor A3(2) which requires calcium for its activity, J. Gen. Microbiol., 1983, 129, 3565–3573
- Huber F.M., Pieper R.L., Tietz A.J., The formation of daptomycin by supplying decanoic acid to Streptomyces roseosporus cultures producing the antibiotic complex A21978C, J. Biotechnol., 1988, 7, 283–292 CrossRef
- Baltz R.H., McHenney M.A. Hosted T.J., Genetics of lipopeptide antibiotic biosynthesis in Streptomyces fradiae A54145 and Streptomyces roseosporus A21978C, In: Developments in Industrial Microbiology, Baltz R.H., Hegeman G.D., Skatrud P.L., (Eds.), Society for Industrial Microbiology, Fairfax, VA, 1997
- Debono M., Abbott B.J., Molloy R.M., Fukuda D.S., Hunt A.H., Daupert V.M., et al., Enzymatic and chemical modifications of lipopeptide antibiotic A21978C: the synthesis and evaluation of daptomycin (LY146032), J. Antibiot. (Tokyo), 1988, 41, 1093–1105
- Gu J.-Q., Nguyen K.T., Gandhi C., Rajgarhia V., Baltz R.H., Brian P., et al., Structural characterization of daptomycin analogues A21978C1-3 (D-Asn11) produced by a recombinant Streptomyces roseosporus strain, J. Nat. Prod., 2007, 70, 233–240 CrossRef
- Cottagnoud P., Daptomycin: a new treatment for insidious due to gram-positive pathogens, Swiss Med. Wkly, 2008, 138, 93–99
- Brody T.M., Larner J., Minneman K.P., Neu H.C., Human Pharmacology: Molecular to Clinical, Mosby, St. Louis, MO, 1994
- Miao V., Coëffet-LeGal M.-F., Brian P., Brost R., Penn J., Whiting A., et al., Daptomycin biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster and revision of peptide stereochemistry, Microbiology, 2005, 151, 1507–1523 CrossRef
- Boeck L.D., Fukuda D.S., Abbott B.J., Debono M., Deacylation of A21978C, an acidic lipopeptide antibiotic complex, by Actinoplanes utahensis, J. Antibiot., 1988, 41, 1085–1092
- Siedlecki J., Hill J., Parr I., Yu X., Morytko M., Zhang Y., et al., Array synthesis of novel lipodepsipeptide, Bioorg. Med. Chem. Lett, 2003, 13, 4245–4249 CrossRef
- Grünewald J., Sieber S.A., Mahlert C., Linne U., Marahiel M.A., Synthesis and derivatization of daptomycin: a chemoenzymatic route to acidic lipopeptide antibiotics, J. Am. Chem. Soc., 2004, 126, 17025–17031 CrossRef
- Huber F.M., Berry D.M., Pieper R.L., Tietz A.J., The synthesis of A21978C analogs by Streptomyces roseosporus cultivated under carbon limitation and fed fatty acids, Biotech. Lett., 1990, 12, 789–792 CrossRef
- Huber F.M., Pieper R.L., Tietz A.J., Dispersal of insoluble fatty acid precursors in stirred bioreactors as a mechanism to control antibiotic factor distribution, In: Ho C.S., Oldshue J.Y., (Eds.), Biotechnology Processes — Scale up and Mixing, American Institute of Chemical Engineers, New York, 1987
- Penn J., Li X., Whiting A., Latif M., Gibson T., Silva C.J., et al., Heterologous production of daptomycin in Streptomyces lividans, J. Ind. Microbiol. Biotechnol., 2006, 33, 121–128 CrossRef
- Muangsiri W., Kirsch L.E., The kinetics of the alkaline degradation of daptomycin, J. Pharm. Sci., 2001, 90, 1066–1075 CrossRef
- Bechinger B., The structure, dynamics and orientation of antimicrobial peptides in membranes by multidimensional solidstate NMR spectroscopy, Biochim. Biophys. Acta, 1999, 1462, 157–183 CrossRef
- Bechinger B., Lohner K., Detergent-like actions of linear amphipathic cationic antimicrobial peptides, Biochim. Biophys. Acta, 2006, 1758, 1529–1539 CrossRef
- Ho S.W., Jung D., Calhoun J.R., Lear J.D., Okon M., Scott W.R.P., et al., Effect of divalent cations on the structure of the antibiotic daptomycin, Euro. Biophysics J., 2008, 37, 421–433. CrossRef
- Jung D., Rozek A., Okon M., Hancock R.E.W., Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin, Chem. Biol., 2004, 11, 949–957 CrossRef
- Straus S.K., Hancock R.E., Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptide and lipopeptides, Biochim. Biophy. Acta, 2006, 1758, 1215–1223 CrossRef
- Jung D., Powers J.P., Straus S.K., Hancock R.E.W., Lipid-specific binding of the calcium-dependent antibiotic daptomycin leads to changes in lipid polymorphism of model membranes, Chem. Phys. Lipids, 2008, 154, 120–128 CrossRef
- Thorne G.M., Alder J., Daptomycin: a novel lipopeptide antibiotic, Clin. Microb. Newsletter, 2002, 25, 33–40 CrossRef
- Silverman J.A., Perlmutter N.G., Shapiro H.M., Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus, Antimicrob. Agents Chemother., 2003, 47, 2538–2544 CrossRef
- Muthaiyan A., Silverman J.A., Jayaswal R.K., Wilkinson B.J., Transcriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulon and genes responsive to membrane depolarization, Antimicrob. Agents Chemother., 2008, 52, 980–990 CrossRef
- English B.K., Maryniw E.M., Talati A.J., Meals E.A., Diminished macrophage inflammatory response to staphylococcus aureus isolates exposed to daptomycin versus vancomycin or oxacillin, Antimicrob. Agents Chemother., 2006, 50, 2225–2227 CrossRef
- Kanafani Z.A., Corey G.R., Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Grampositive infections, Expert Rev. Anti Infect. Ther., 2007, 5, 177–184 CrossRef
- Nguyen K.T., Ritz D., Gu J.-Q., Alexander D., Chu M., Miao V., et al., Combinatorial biosynthesis of novel antibiotics related to daptomycin, Proc. Natl. Acad. Sci. USA, 2006, 103, 17462–17467 CrossRef
- Kopp F., Grunewald J., Mahlert C., Marahiel M.A., Chemoenzymetic design of acidic lipopeptide hybrids: new insights into the structure-activity relationship of daptomycin and A54145, Biochemistry, 2006, 45, 10474–10481 CrossRef
- Eliopoulos G.M., Willey S., Reiszner E., Spitzer P.G., Caputo G., Moellering R., In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic, Antimicrob. Agents Chemother., 1986, 30, 532–535
- Andrew J.H., Wale M.C., Wale L.J., Greenwood D., The effect of cultural conditions on the activity of LY146032 against staphylococci and streptococci, J. Antimicrob. Chemother., 1987, 20, 213–221 CrossRef
- Chow A.W., Cheng N., In vitro activities of daptomycin (LY146032) and paldimycin (U-70, 138F) against anaerobic Gram-positive bacteria, Antimicrob. Agents Chemother., 1988, 32, 788–790
- Ball L.J., Goult C.M., Donarsi J.A., Micklefield J., Ramesh V., NMR strcture determination and calcium binding effects of lipopeptide antibiotic daptomycin”, Org. Biomol. Chem., 2004, 2, 1872–1878 CrossRef
- Rotondi K.S., Gierasch L.M., A well defined amphipathic conformation for the calcium- free cyclic lipopeptide antibiotic, daptomycin, in aqueous solution, Biopolymers, 2005, 80, 374–385 CrossRef
- Scott W.R.P., Baek S.-B., Jung D., Hancock R.E.W., Straus S.K., NMR structural studies of the antibiotic lipopeptide daptomycin in DHPC micelles, Biochim. Biophys. Acta, 2007, 1768, 3116–3126 CrossRef
- Van Bambeke F., Mingeot-Leclercq M.P., Struelens M.J., Tulkens P.M. The bacterial envelope as a target for novel anti-MRSA antibiotics, Trends Pharmacol. Sci., 2008, 29, 124–134
- Doekel S., Coëffet-Le Gal M.-F., Gu J.-Q., Chu M., Baltz R.H., Brian P., Non-ribosomal peptide synthetase module fusions to produce derivatives of daptomycin in Streptomyces roseosporus, Microbiology, 2008, 154, 2872–2880 CrossRef
- Kato A., Nakaya S., Kokubo N., Aiba Y., Ohashi Y., Hirata H., A new anti-MRSA antibiotic complex, WAP-8294A. I. Taxonomy, isolation and biological activities, J. Antibiot., 1998, 51, 929–935
- Nakaya S., Ohashi Y., Hirata H., Fujii K., Harada K.-I., WAP-8294A2, A novel anti-MRSA antibiotic reduced by Lysobacter sp., J. Am. Chem. Soc., 1997, 119, 6680–6681 CrossRef
- Kato A., Nakaya S., Suzuki N., Aiba Y., Kokubo N., Hirata H., et al., Tennen Yuki Kagobutsu Toronkai Koen Yoshishu, 1997, 39th, 253, (Chem. Abstr., 1999, 131, 115328)
- Harada K.-I., Suzuki M., Kato A., Fuji K., Oka H., Ito Y., Separation of WAP-8294A components, a novel anti-methicillin-resistant Staphylococcus aureus antibiotic using high-speed counter-current chromatography, J. Chromat. A, 2001, 932, 75–81 CrossRef
- Jones T.S.G., Chemical evidence for the multiplicity of the antibiotics produced by Bacillus polymyxa, Annals of the New York Academy of Sciences, 1949, 51, 909–916 CrossRef
- Hausmann W., The Amino Acid Sequence of Polymyxin B1, J. Am. Chem. Soc., 1956, 78, 3663–3667 CrossRef
- Biserte G.A, Dautrevaux M., Structure of polymyxin B, Bull. Soc. Chim. Biol.,1957, 795–812
- Vogler K., Studer R.O., Lanz P., Lergier W., Böhni E., Total synthesis of two cyclodecapeptides exerting polymyxin-like activity, Experientia, 1961, 17, 223–224 CrossRef
- Orwa J.A., Govaerts C., Busson R., Roets E., Van Schepdael A., Hoogmartens J., Isolation and structural characterization of polymyxin B components, J. Chromat. A, 2001, 912, 369–373 CrossRef
- Li J., Nation R.L., Milne R.W., Turnidge J.D., Coulthard K., Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria, Int. J. Antimicrob. Agents, 2005, 25, 11–25 CrossRef
- Li J., Milne R.W., Nation R.L., Turnidge J.D., Coulthard K., Valentine J., Simple method for assaying colistin methanesulfonate in plasma and urine using high-performance liquid chromatography, Antimicrob. Agents Chemother., 2002, 46, 3304–3307 CrossRef
- Duwe A.K., Rupar C.A., Horsman G.B., Vas S.I., In vitro cytotoxicity and antibiotic activity of polymyxin B nonapeptide, Antimicrob. Agents Chemother., 1996, 30, 340–341
- Storm D.R., Rosenthal K.S., Swanson P.E., Polymyxin and related peptide antibiotics, Annu. Rev. Biochem., 1977, 46, 723–763 CrossRef
- Danner R.L., Joiner K.A., Rubin M., Paterson W.H., Johnson N., Ayers K.M., et al., Purification, toxicity, and antiendotoxin activity of polymyxin B nonapeptide, Antimicrob. Agents Chemother. 1989, 33, 1428–1434
- Vaara M., Agents that increase the permeability of the outer membrane, Microbiol. Rev., 1992, 56, 395–411
- Vaara M., Vaara T., Sensitization of Gram-negative bacteria to antibiotics and complement by a nontoxic oligopeptide, Nature, 1983, 303, 526–528 CrossRef
- Vaara M., Vaara T., Polycations sensitize enteric bacteria to antibiotics, Antimicrob. Agents Chemother., 1983, 24, 107–113
- Vaara M., Vaara T., Polycations as outer membrane-disorganizing agents, Antimicrob. Agents Chemother., 1983, 24, 114–122
- Ito-Kagawa M., Koyama Y., Studies on the selectivity of action of colistin, colistin nonapeptide and colistin heptapeptide on the cell envelope of Escherichia coli, J. Antibiot., 1984, 37, 926–928
- Lam C., Hildebrandt J., Schutze E., Wenzel A.F., Membrane-disorganizing property of polymyxin B nonapeptide, J. Antimicrob. Chemother., 1986, 18, 9–15 CrossRef
- McCashion R.N., Lynch W.H., Effects of polymyxin B nonapeptide on Aeromonas salmonicida,Antimicrob. Agents Chemother., 1987, 31, 1414–1419
- Kubesch P., Whesling M., Tummler B., Membrane permeability of Pseudomonas aeruginosa to 4-quinolones, Zentralbl. Bakteriol. Mikrobiol. Hyg. ABT. 1, 1987, 265, 197–202
- Moestrup S.K., Cui S., Vorum H., Bregengård C., Bjorn S.E., Norris K., et al., Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs, J. Clin. Investig., 1995, 96, 1404–1413 CrossRef
- Vaara M., Fox J., Loidl G., Siikanen O., Apajalahti J., Hansen F., et al., Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents, Antimicrob. Agents Chemother., 2008, 52, 3229–3236 CrossRef
- Tsubery H., Ofek I., Cohen S., Fridkin M., The functional association of polymyxin B with bacterial lipopolysaccharide is stereospecific: studies on polymyxin B nonapeptide, Biochemistry, 2000, 39, 11838–11844 CrossRef
- Heineman B., Kaplan M.A., Muir R.D., Hooper I.R., Amphomycin, a new antibiotic, Antibiot. Chemother., 1953, 3, 1239–1242
- Bodanszky M., Chaturvedi N.C., Scozzie J.A., The structure of fatty acids from the antibiotic amphomycin, J. Antibiot., 1969, 22, 399–408
- Bodanszky M., Siegler G.F., Bodanszky A., Structure of the peptide antibiotic Amphomycin, J. Am. Chem. Soc., 1973, 95, 2352–2357 CrossRef
- Wacowich-Sgarbi S.A., Boyd V.A., Cameron D.R., Chen Y., Dugourd D., Jia Q., et al., Synthesis and Structure-Activity Relationship (SAR) Studies on Dab-9 Substitutions of the Lipopeptide Antibiotic Amphomycin, presented at the 229th National ACS (American Chemical Society Meeting) Meeting & Exposition, San Diego, CA, 13–17 March 2005
- Sgarbi P.W.M., Boyd V.A., Cameron D.R., Chen Y., Jia Q., Nodwell M., et al., Synthesis and structureactivity relationship (SAR) studies on the lipophilic tail of the lipopeptide antibiotic Amphomycin, presented at the 229th National ACS (American Chemical Society Meeting) Meeting & Exposition, San Diego, CA, 13–17 March 2005
- Cameron D.R., Lipopeptides: SAR and synthesis of a new class of semi-synthetic antibiotics, presented at the 88th Canadian Chemistry Conference (CSC) and Exhibition, Saskatoon, CDN, 28 May–1 June 2005
- Yang H., Clement J.J., Dugourd D., MX-2401 bactericidal activity and membrane depolarization in Staphylococcus epidermidis, F1-364, presented at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and the concurrent 46th Annual Infectious Diseases Society of America (IDSA) meeting, Washington, DC, 25–28 October 2008
- Benz F., Knusel F., Nuesch J., Treichler H., Voser W., Nyfeler R., et al., Echinocandin B, ein neuartiges Polypeptid-Antibiotikum aus Aspergillus nidulans var. echinulatus: Isolierung und Bausteine, Helv. Chim. Acta, 1974, 57, 2459–2477 CrossRef
- Keller-Juslen C., Kuhn M., Loosli H.-R., Petcher T.J., Weber H.P., von Wartburg A., Struktur des Cyclopeptid-Antibiotikums SL 7810 (= Echinocandin B), Tetrahedron Lett., 1976, 4147–4150, (in German)
- Koyama G., The crystal and molecular structure of 3-hydroxy-4-methyl-proline, Helv. Chim. Acta, 1974, 57, 2477–2483 CrossRef
- von Traber R., Keller-Juslen C., Loosli H.-R., Kuhn M., von Wartburg A., Cyclopeptid-Antibiotika aus Aspergillus-Arten. Struktur der Echinocandine C und D, Helv. Chim. Acta, 1979, 62, 1252–1267, (in German) CrossRef
- Kurokawa N., Ohfune Y., Total synthesis of echinocandins. 1. Stereocontrolled syntheses of the constituent amino acids, J. Am. Chem. Soc., 1986, 108, 6041–6043 CrossRef
- Kurokawa N., Ohfune Y., Total synthesis of Echinocandins. 2. Total synthesis of Echinocandins D via efficient peptide coupling reactions, J. Am. Chem. Soc., 1986, 108, 6043–6045 CrossRef
- Balbovec J.M., Black R.M., Hammond M.L., Heck J.V., Zambias R.A., Abruzzo G., et al., Synthesis, Stability and biological evaluation of water soluble prodrugs of a new Echinocandin Lipopeptide. Discovery of a potential clinical agent for the treatment of systemic Candidiasis and Pneumocystis Carinii Pneumonia (PCP), J. Med. Chem, 1992, 35, 194–198 CrossRef
- Taft C.S., Selitrennikoff C.P., Cilofungin Inhibition of (1,3)-β-glucan synthesis: the lipophilic side chain is essential for inhibition of enzyme activity, J. Antibiot., 1990, 43, 433–437
- Debono M., Abbott B.J., Fukuda D.S., Barnhart M., Willard K.E., Molloy R.M., et al., Synthesis of new analogs of Echinocandin B by enzymatic deacylation and chemical reacylation of the Echinocandin B peptide: Synthesis of the antifungal agent Cilofungin (LY121019), J. Antibiot., 1989, 42, 389–397
- Boeck L.D., Fukuda D.S., Abbott B.J., Debono M., Deacylation of Echinocandin B by Actinoplanes utahensis, J. Antibiot., 1989, 42, 382–388
- Debono M., Abbott B.J., Turner J.R., Howard L.C., Gordee R.S., Hunt A.H., et al., Synthesis and evaluation of LY121019, a member of a series of semi-synthetic analogues of the antifungal lipopeptide Echinocandin B, Ann. N.Y. Acad. Sci., 1988, 544, 152–167 CrossRef
- Diekema D.J., Petroelje B., Messer S.A., Hollis R.J., Pfaller M.A., Activity of available and investigational antifungal agents against Rhodotorula species, J. Clin. Microbiol., 2005, 43, 476–478 CrossRef
- Nasto B., Biotech at the beauty counter, Nat. Biotechnol., 2007, 25, 617–619 CrossRef
- Rinaldi A., Healing beauty? More biotechnology cosmetic products that claim drug-like properties reach the market, EMBO Reports, 2008, 9, 1073–1077 CrossRef
- Nagarajan R., Schabel A.A., Occolowitz J.L., Counter F.T., Ott J.L., Felty-Duckworth A.M., Synthesis and antibacterial evaluation of N-alkyl vancomycins., J. Antibiot. (Tokyo), 1989, 42, 63–72
- Nagarajan R., Structure-activity relationships of vancomycin-type glycopeptide antibiotics, J. Antibiot. (Tokyo), 1993, 46, 1181–1195
- Higgins D.L., Chang R., Debabov D.V., Leung J., Wu T., Krause K.M., et al., Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother., 2005, 49, 1127–1134 CrossRef
- Leadbetter M.R., Adams S.M., Bazzini B., Fatheree P.R., Karr D.E., Krause K.M., et al., Hydrophobic vancomycin derivatives with improved ADME properties: discovery of telavancin (TD-6424), J. Antibiot. (Tokyo), 2004, 57, 326–336
- Xiong Y.Q., Yeaman M.R., Bayer A.S., In vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action, Antimicrob. Agents Chemother., 1999, 43, 1111–1117
- Yeaman M.R., Bayer A.S., Koo S.P., Foss W., Sullam P.M., Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action, J. Clin. Investig., 1998, 101, 178–187 CrossRef
- Judice J.K., Pace J.L., Semi-synthetic glycopeptide antibacterials, Bioorg. Med. Chem. Lett., 2003, 13, 4165–4168 CrossRef
About this Article
- Title
- Lipopeptides as anti-infectives: a practical perspective
- Journal
-
Central European Journal of Biology
Volume 4, Issue 3 , pp 258-273 - Cover Date
- 2009-09-01
- DOI
- 10.2478/s11535-009-0031-3
- Print ISSN
- 1895-104X
- Online ISSN
- 1644-3632
- Publisher
- SP Versita
- Additional Links
- Topics
- Keywords
-
- Lipopeptides
- Antimicrobial peptides
- Antibiotics
- Semi-synthetic analogues
- Daptomycin
- Polymyxin
- Echinocandin
- Lipid membranes
- LPS
- Authors
-
-
Giovanna Pirri
(1)
- Andrea Giuliani (1)
- Silvia Fabiole Nicoletto (1)
- Lorena Pizzuto (1)
- Andrea C. Rinaldi (2)
-
Giovanna Pirri
- Author Affiliations
-
- 1. Research s& Development Unit, Spider Biotech S.r.l, I-10010, Colleretto Giacosa, Italy
- 2. Department of Biomedical Sciences and Technologies, University of Cagliari, 09042, Cagliari, Italy